Form 4: Director Nicolas Gikakis Adjusts Aethelon Medical Holdings

Director Nicolas Gikakis reported a transaction involving the forfeiture of 2,182 shares of common stock to cover tax withholdings related to the conversion of restricted stock units.

Summary

• Director Nicolas Gikakis has reported a transaction on June 30, 2026.
• This transaction involved the forfeiture of 2,182 shares of common stock.
• The forfeiture was to cover tax withholdings upon the conversion of 5,454 vested restricted stock units into common stock.
• The value used for tax withholding was the market price of Aethelon Medical Inc.'s common stock at the time of forfeiture.
• These restricted stock units were part of a grant previously reported on April 17, 2026.
• Following this transaction, Gikakis beneficially owns 20,663 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, as it represents a routine administrative transaction for tax purposes rather than a strategic decision to buy or sell shares based on company performance or outlook.

Positives

• The transaction addresses tax obligations related to stock unit conversion, ensuring compliance.
• The reporting person continues to hold a significant number of shares (20,663) directly, indicating ongoing investment.

Negatives

• A forfeiture of shares, even for tax purposes, represents a reduction in the total number of shares held by the reporting person.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which details a past transaction.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. This specific filing details a common practice of using company stock to cover tax liabilities upon the vesting and conversion of equity awards.

Stakeholder Impact

• Shareholders: The forfeiture reduces the total number of shares held by a director, but the underlying equity award was previously granted and vested, so the impact on overall ownership structure is minimal and expected.
• Employees: This filing is specific to director compensation and equity awards, with no direct impact on general employees.
• Management: The transaction reflects standard procedures for managing equity compensation and tax liabilities.

Key Dates

Keywords

Form 4, SEC Filing, Beneficial Ownership, Stock Options, Restricted Stock Units, Tax Withholding, Insider Transaction, Aethelon Medical Inc., Nicolas Gikakis